Overview

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Status:
Withdrawn
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the most effective way to control post-operative breast pain for patients undergoing a unilateral, immediate breast reconstruction.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Treatments:
Bupivacaine
Narcotics